Jason Russell Chambers, Director at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), sold 5,000 shares at $7.30 ($37K) on 2014-08-14, disclosed to the SEC on 2014-08-14.
Open-market sale of $36k HRT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HRT | SELL | 2015-06-16 | $8K | — | Filing → |
| HRT | BUY | 2008-09-16 | $32K | — | Filing → |
| HRT | BUY | 2008-09-15 | $4K | — | Filing → |